Amphastar Pharmaceuticals, Inc. AMPH Income Statement

Amphastar pharmaceuticals, inc. (AMPH)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Sep'13	Jun'13
Net revenues
327,255	322,357	328,664	324,070	316,063	294,666	265,378	247,751	241,898	240,175	243,316	249,623	252,469	255,165	268,534	268,179	253,999	251,519	230,484	226,327	221,477	210,461	213,902	216,715	0	0	0
Cost of revenues
189,412	190,434	195,433	196,831	195,147	187,681	172,701	163,781	157,245	149,666	153,220	152,468	150,347	150,969	151,135	160,814	165,030	174,172	174,347	175,977	169,449	159,205	154,327	141,442	0	0	0
Gross profit
137,843	131,923	133,231	127,239	120,916	106,985	92,677	83,970	84,653	90,509	90,096	97,155	102,122	104,196	117,399	107,365	88,969	77,347	56,137	50,350	52,028	51,256	59,575	75,273	0	0	0
Operating (income) expenses:
Selling, distribution, and marketing
12,983	12,830	11,950	10,692	9,576	8,156	7,189	6,982	6,702	6,460	6,322	5,857	5,593	5,466	5,282	5,162	5,300	5,470	5,662	5,945	5,827	5,564	5,527	5,276	0	0	0
General and administrative
44,698	50,279	53,588	55,974	55,217	49,888	45,295	43,553	44,118	44,458	45,940	45,076	42,300	41,832	39,840	38,073	39,923	41,504	42,563	43,085	40,415	34,809	34,584	31,541	0	0	0
Research and development
69,549	68,853	65,943	58,677	58,141	57,564	52,276	51,011	46,283	43,503	44,657	44,305	44,167	41,522	37,782	39,176	39,308	37,271	36,489	33,957	29,225	28,866	29,829	29,035	0	0	0
Gain on sale of intangible assets
-	-	-	-	-	-	-	-	-	2,643	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of long-lived assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	367	354	0	0	0
Total operating expenses
127,230	131,962	131,481	125,343	122,934	115,608	104,760	101,546	97,103	91,778	94,276	92,595	89,417	88,820	82,826	82,337	84,531	84,245	84,431	82,713	75,303	69,239	70,307	66,206	0	0	0
Income (loss) from operations
10,613	-39	1,750	1,896	-2,018	-8,623	-12,083	-17,576	-12,450	-1,269	-4,180	4,560	12,705	15,376	34,573	25,028	4,438	-6,898	-28,294	-32,363	-23,275	-17,983	-10,732	9,067	0	0	0
Non-operating (expenses) income:
Interest income
1,002	997	862	517	480	456	458	477	458	425	385	324	287	270	262	282	297	315	329	340	307	243	203	156	0	0	0
Interest expense
165	119	77	179	255	243	376	516	653	826	746	763	831	1,024	1,174	1,125	1,030	987	232	504	770	609	1,355	1,088	0	0	0
Other income (expenses), net
58,216	59,389	57,096	58,389	-2,877	-1,516	172	1,098	3,501	2,919	2,165	1,618	157	8	-3,754	-4,555	-4,056	-2,794	1,678	2,300	1,864	201	-112	-228	0	0	0
Total non-operating (expenses) income, net
59,053	60,267	57,881	58,727	-2,652	-1,303	254	1,059	3,306	2,518	1,804	1,179	-387	-746	-4,666	-5,398	-4,789	-3,466	1,775	2,136	1,401	-165	-1,264	-1,160	0	0	0
Income (loss) before income taxes
69,666	60,228	59,631	60,623	-4,670	-9,926	-11,829	-16,517	-9,144	1,249	-2,376	5,739	12,318	14,630	29,907	19,630	-351	-10,364	-26,519	-30,227	-21,874	-18,148	-11,996	7,907	0	0	0
Income tax provision (benefit)
17,482	13,723	12,163	12,523	-2,997	-3,266	-4,134	-7,305	-4,757	-2,398	-1,886	2,438	4,094	4,810	9,100	5,721	-718	-7,577	-13,678	-15,015	-12,129	-7,449	-3,659	3,055	0	0	0
Net income (loss)
52,184	46,505	47,468	48,100	-1,673	-6,660	-8,279	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to non-controlling interests
164	-2,434	-4,988	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income (loss) attributable to Amphastar Pharmaceuticals, Inc.
52,020	48,939	51,832	52,911	2,271	-5,738	-6,922	-9,212	-4,387	3,647	-490	3,301	8,224	9,820	20,807	13,909	367	-2,787	-12,841	-15,212	-9,745	-10,699	-8,337	4,852	0	0	0
Net income (loss) per share attributable to Amphastar Pharmaceuticals, Inc. shareholders:
Basic (in Dollars per share)
0.09	-0.02	0.03	1.01	0.02	0.04	0.05	-0.06	-0.15	0.02	0.00	0.04	0.02	-0.08	0.09	0.15	0.06	0.17	-0.07	-0.15	-0.01	-0.06	-0.12	-0.03	-0.04	0.00	0.20
Diluted (in Dollars per share)
0.08	-0.03	0.03	0.96	0.02	0.04	0.05	-0.06	-0.15	0.02	0.00	0.04	0.02	-0.07	0.08	0.15	0.05	0.17	-0.07	-0.15	-0.01	-0.06	-0.12	-0.03	-0.04	0.00	0.20
Weighted-average shares used to compute net income (loss) per share attributable to Amphastar Pharmaceuticals, Inc. shareholders:
Basic (in Shares)
46,408	46,838	47,239	47,107	46,744	46,268	46,241	46,557	46,514	46,233	46,101	46,025	46,069	46,104	45,398	44,957	45,041	45,084	45,310	44,849	44,601	44,648	44,644	39,767	38,769	38,709	38,708
Diluted (in Shares)
48,248	49,243	50,075	49,894	50,416	44,228	48,281	46,557	46,514	49,330	48,215	47,866	48,057	49,285	47,953	45,968	46,810	45,084	45,310	44,849	44,601	44,648	44,644	39,767	38,769	38,709	38,847